Free Trial
OTCMKTS:AXIM

AXIM Biotechnologies (AXIM) Stock Price, News & Analysis

AXIM Biotechnologies logo
$0.0041 +0.00 (+5.13%)
As of 04/17/2025 01:40 PM Eastern

About AXIM Biotechnologies Stock (OTCMKTS:AXIM)

Key Stats

Today's Range
$0.0041
$0.0049
50-Day Range
N/A
52-Week Range
$0.0013
$0.0190
Volume
387,186 shs
Average Volume
438,141 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

AXIM Biotechnologies, Inc. engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

Receive AXIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AXIM Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

AXIM Stock News Headlines

My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by using a secret we tested against every horrible thing that's happened to our financial system since 1991.
AXIM Biotechnologies, Inc. (AXIM)
AXIM Biotechnologies Inc AXIM
ADPT Adaptive Biotechnologies Corporation
See More Headlines

AXIM Stock Analysis - Frequently Asked Questions

AXIM Biotechnologies' stock was trading at $0.0019 at the beginning of the year. Since then, AXIM shares have increased by 115.8% and is now trading at $0.0041.
View the best growth stocks for 2025 here
.

Shares of AXIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AXIM Biotechnologies investors own include Cronos Group (CRON), Canopy Growth (CGC), Tilray (TLRY), Charlotte's Web (CWBHF), Baidu (BIDU), Meta Platforms (META) and Micron Technology (MU).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:AXIM
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:AXIM) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners